1. Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor
   Ziyan Y. Pessetto et al, 2014, Molecular Cancer Therapeutics CrossRef
2. Physiologically Based Pharmacokinetic Modelling with Dynamic PET Data to Study the In Vivo Effects of Transporter Inhibition on Hepatobiliary Clearance in Mice
   Marco F. Taddio et al, 2018, Contrast Media & Molecular Imaging CrossRef
3. Characteristics of Ibritumomab as Radionuclide Therapy Agent
   Hidekazu Kawashima, 2018, Resistance to Ibritumomab in Lymphoma CrossRef
4. Advances in targeted therapy for malignant lymphoma
   Li Wang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
5. Role of the tumor microenvironment in regulating apoptosis and cancer progression
   Katherine Yaacoub et al, 2016, Cancer Letters CrossRef
6. Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
   Stefania Crisci et al, 2019, Medicina CrossRef
7. The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer
   Jun-Ying Xu et al, 2019, Pancreas CrossRef
8. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma
   Jungah Kim et al, 2023, Acta Biomaterialia CrossRef